Q BioMed (OTCQB:QBIO) and its key technology partners are set to initiate a diagnostic kit for monitoring glaucoma severity and progression. Pending FDA clearance, this kit will preserve visual ...
South Korea’s health care solutions developer MiCo BioMed claimed Wednesday it has developed a rapid molecular diagnostic system to detect the novel coronavirus with high sensitivity within an hour.
The way students study DNA strands has met its match with a new genome test kit produced by a Tempe company. The product, marketed by GenoSensor Corp., is called the EduPrimerTM DNA Profiling Kit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback